The DOI matches its Crossref record.
L-Asparaginase: Therapeutic and Toxic Effects in Patients with Neoplastic Disease
Abstract
Escherichia coli L-asparaginase (NSC-109229) was administered to 55 patients with neoplastic diseases. Two thirds of the patients received 200 IU per kilogram per day, but others received doses ranging from 50 to 2000 IU per kilogram per day. Responses were restricted to a patient with melanoma, four patients with lymphoma and 11 patients with leukemia. The complete remission rate was 26 per cent in patients with acute lymphatic leukemia, with a median remission duration of nine weeks. Most patients tolerated L-asparaginase; however, severe toxicity appeared in a variety of forms. Hypersensitivity occurred in 14 of the patients. Depression of clotting factors occurred in 16 of 20 evaluable patients, liver dysfunction in 33 of 35 evaluable patients, Central-nervous-system disturbances in 18 of 35 evaluable adults (but none of the children), pancreatitis in six patients, and renal failure in two patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Andrade, R. J., Chalasani, N., Björnsson, E. S., Suzuki, A., Kullak-Ublick, G. A., Watkins, P. B., Devarbhavi, H., Merz, M., Lucena, M. I., Kaplowitz, N., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0105-0 · Cited by 924
Pharmacological and clinical evaluation of l-asparaginase in the treatment of leukemia
Narta, U. K., Kanwar, S. S., & Azmi, W. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2006.07.009 · Cited by 384
Metadata
- Authors
- Haskell, C. M., Canellos, G. P., Leventhal, B. G., Carbone, P. P., Block, J. B., Serpick, A. A., & Selawry, O. S.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1969-11-06
- Volume
- 281
- Issue
- 19
- Pages
- 1028-1034
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2020589011
- Cited by
- 263
- References
- 0
- FWCI
- 33.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: L-Asparaginase: Therapeutic and Toxic Effects in Patients with Neoplastic Disease. https://app.cochat.ai/papers/10.1056/nejm196911062811902
- The paper
- Haskell, C. M., Canellos, G. P., Leventhal, B. G., Carbone, P. P., Block, J. B., Serpick, A. A., & Selawry, O. S. (1969). L-Asparaginase: Therapeutic and Toxic Effects in Patients with Neoplastic Disease. New England Journal of Medicine. https://doi.org/10.1056/nejm196911062811902
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
